Leerink Partnrs Brokers Raise Earnings Estimates for PLRX
Pliant Therapeutics, Inc. (NASDAQ:PLRX - Free Report) - Equities research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for Pliant Therapeutics in a research note issued to investors on Monday, March 3rd. Leerink Partnrs analyst F. Khurshid now anticipates that the company wil.
Publicado el: 2025-03-07 12:18:46
Autor: lulegacy, Fuente: lulegacy
Compartir: 
